Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Cape Fear Valley Medical Center located at 1638 Owen Dr, Fayetteville, NC, 28304 & includes data from NPIs 1639172869, 1821091851
Dexur analyzed Q3 2019 (July to September 2019) Medicare claims data to benchmark length of stay (LOS) outcomes for Cape Fear Valley Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,673 | 2,487 | ||||||||||
| Surgical | 516 | 493 | ||||||||||
| Non Surgical | 2,157 | 1,994 | ||||||||||
| Cardiovascular | 612 | 571 | ||||||||||
| General Medicine | 449 | 397 | ||||||||||
| Gastroenterology & Endocrinology | 305 | 289 | ||||||||||
| Urology | 266 | 256 | ||||||||||
| Pulmonology | 239 | 218 | ||||||||||
| Orthopedics | 226 | 220 | ||||||||||
| Neurology | 222 | 205 | ||||||||||
| General Surgery | 140 | 126 | ||||||||||
| Oncology & Hematology | 81 | 77 | ||||||||||
| Psychiatry & Mental Disorders | 63 | 60 | ||||||||||
| Colorectal | 20 | 19 | ||||||||||
| Spine | 19 | 19 | ||||||||||
| Obstetrics & Gynecology | 16 | 16 | ||||||||||
| Dermatology | 11 | NA |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hypertension | ||||||||||||
| DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 304: HYPERTENSION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| Coronary Bypass | ||||||||||||
| Permanent Cardiac Pacemaker Implant |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Signs And Symptoms | ||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| Aftercare | ||||||||||||
| DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| Disequilibrium | ||||||||||||
| DRG 149: DYSEQUILIBRIUM |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 379: G.I. HEMORRHAGE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| Cholecystectomy | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| Disorders Of Biliary Tract |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Ureter Procedures |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Pulmonary Embolism | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 559: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||
| DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Disorders Of Nervous System |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hernia Procedures | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Neoplasms |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | North Carolina Total Hospitalizations (Jul 2019 to Sep 2019) | North Carolina Total Hospitalizations After Exclusion | North Carolina Total Users | North Carolina Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |